Trinity Biotech Announces Q3 2022 Financial Results
December 15, 2022 09:05 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech plc to Announce Third Quarter Fiscal Year 2022 Financial Results
December 09, 2022 05:35 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Dec. 09, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech to participate in the Piper Sandler 34th Annual Healthcare Conference
November 30, 2022 05:50 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...
Trinity Biotech Announces Quarter 2 2022 Financial Results And Preliminary Q3 2022 Revenue Guidance
November 03, 2022 09:00 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech plc to Announce Second Quarter Fiscal Year 2022 Financial Results
November 01, 2022 09:15 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech Announces the Appointment of Tom Lindsay to its Board of Directors
October 26, 2022 08:30 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech Announces The Appointment of Aris Kekedjian As Chairman and CEO
October 03, 2022 08:50 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech Announces Results of AGM
September 30, 2022 09:00 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech Announces Quarter 1 2022 Financial Results
June 30, 2022 09:07 ET
|
Trinity Biotech plc
DUBLIN, Ireland, June 30, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
Trinity Biotech plc to Announce First Quarter Fiscal Year 2022 Financial Results
June 29, 2022 17:20 ET
|
Trinity Biotech plc
DUBLIN, Ireland, June 29, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...